Genetics, epigenetics and environment may together affect the susceptibility for type 2 diabetes (T2D). Our aim was to dissect molecular mechanisms underlying T2D using genome-wide expression and DNA methylation data in adipose tissue from monozygotic twin pairs discordant for T2D and independent case-control cohorts. In adipose tissue from discordant twins, we found decreased expression of genes involved in oxidative phosphorylation, carbohydrate-, amino acid- and lipid metabolism, and increased expression of genes involved in inflammation and glycan degradation. The most differentially expressed genes included ELOVL6, GYS2, FADS1, SPP1 (OPN), CCL18 and IL1RN. We replicated these results in adipose tissue from an independent case-control c...
Although genetic variations and environmental factors are vital to the development and progression o...
Aim: First-degree relatives (FDR) of individuals with Type 2 diabetes (T2D) feature restricted adipo...
The prevalence of type 2 diabetes (T2D) is increasing worldwide, but current treatments have limitat...
Background: Monozygotic twins discordant for type 2 diabetes constitute an ideal model to study envi...
BACKGROUND: Monozygotic twins discordant for type 2 diabetes constitute an ideal model to study envi...
BACKGROUND: Obesity is a well-recognized risk factor for insulin resistance and type 2 diabetes (T2D...
Abstract Background Obesity is a well-recognized risk factor for insulin resistance and type 2 diabe...
Background: Type 2 diabetes (T2D) is a multifactorial, polygenic disease caused by impaired insulin ...
Type 2 diabetes (T2D) develops due to insulin resistance and impaired insulin secretion, predominant...
Abstract Type 2 diabetes is a complex trait with both environmental and hereditary factors contribut...
The twin epidemics of obesity and type 2 diabetes (T2D) are a serious health, social, and economic i...
Failure in glucose response to insulin is a common pathology associated with obesity. In this study,...
DNA methylation has a great potential for understanding the aetiology of common complex traits such ...
<div><p>Aims/Hypothesis</p><p>Failure in glucose response to insulin is a common pathology associate...
DNA methylation has a great potential for understanding the aetiology of common complex traits such ...
Although genetic variations and environmental factors are vital to the development and progression o...
Aim: First-degree relatives (FDR) of individuals with Type 2 diabetes (T2D) feature restricted adipo...
The prevalence of type 2 diabetes (T2D) is increasing worldwide, but current treatments have limitat...
Background: Monozygotic twins discordant for type 2 diabetes constitute an ideal model to study envi...
BACKGROUND: Monozygotic twins discordant for type 2 diabetes constitute an ideal model to study envi...
BACKGROUND: Obesity is a well-recognized risk factor for insulin resistance and type 2 diabetes (T2D...
Abstract Background Obesity is a well-recognized risk factor for insulin resistance and type 2 diabe...
Background: Type 2 diabetes (T2D) is a multifactorial, polygenic disease caused by impaired insulin ...
Type 2 diabetes (T2D) develops due to insulin resistance and impaired insulin secretion, predominant...
Abstract Type 2 diabetes is a complex trait with both environmental and hereditary factors contribut...
The twin epidemics of obesity and type 2 diabetes (T2D) are a serious health, social, and economic i...
Failure in glucose response to insulin is a common pathology associated with obesity. In this study,...
DNA methylation has a great potential for understanding the aetiology of common complex traits such ...
<div><p>Aims/Hypothesis</p><p>Failure in glucose response to insulin is a common pathology associate...
DNA methylation has a great potential for understanding the aetiology of common complex traits such ...
Although genetic variations and environmental factors are vital to the development and progression o...
Aim: First-degree relatives (FDR) of individuals with Type 2 diabetes (T2D) feature restricted adipo...
The prevalence of type 2 diabetes (T2D) is increasing worldwide, but current treatments have limitat...